Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans

被引:12
作者
Boxx, Gayle M. [1 ]
Nishiya, Casey T. [1 ]
Kozel, Thomas R. [2 ]
Zhang, Mason X. [1 ]
机构
[1] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA
[2] Univ Nevada, Dept Microbiol & Immunol, Sch Med, Reno, NV 89557 USA
基金
美国国家卫生研究院;
关键词
Complement; Candida; Alternative pathway; C3; convertase; Factor B; Antimannan antibody; Fab; Fc-independent; HEMATOGENOUSLY DISSEMINATED CANDIDIASIS; IMMUNOGLOBULIN-G ANTIBODIES; IGG3; MONOCLONAL-ANTIBODY; COMPLEMENT PATHWAY; HUMAN SERUM; IMMUNE-RESPONSES; CRYPTOCOCCUS-NEOFORMANS; ESCHERICHIA-COLI; FACTOR-H; ACTIVATION;
D O I
10.1016/j.molimm.2008.10.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The complement system has an important role in host resistance to systemic candidiasis but regulation of complement activation by Candida albicans remains poorly defined. Previous Studies have identified a requirement for naturally occurring antimannan IgG antibody in initiation of C3 opsonization of C. albicans through either the classical or alternative pathway. This study characterized antibody-dependent initiation of the alternative pathway using the recombinant human monoclonal antimannan Fab fragment M1 and its full-length IgG1 antibody M1g1. Kinetic analysis of C3b deposition onto C. albicans with flow cytometry demonstrated the ability of M1g1 to restore the activity of either the classical or alternative pathway to the yeast-absorbed normal human serum, but the Fc-free M1 Fab restored only the activity of the alternative pathway. This Fc-independent, antimannan Fab-mediated C3 deposition through the alternative pathway was also observed in a serum-free assay containing the six alternative pathway proteins and in C1q- or C2-depleted serum but not in factor B-depleted serum. M1- or M1g1-dependent alternative pathway initiation of C3b deposition occurred in an asynchronous manner at discrete sites that expanded to cover the entire cell Surface over time as revealed with immunofluorescence microscopy, ill Contrast to a uniform appearance of initial C3 deposition through the Classical pathway. Furthermore, antimannan Fab M I promoted the assembly of the alternative pathway convertase oil the cell surface seen as colocalization of C3 and factor B with immunoflurescence microscopy. Thus, human antimannan antibody has a distinct Fc-independent effector function in regulation Of C3 deposition to C. albicans. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:473 / 480
页数:8
相关论文
共 47 条
[1]
STRUCTURAL REQUIREMENTS OF RABBIT IGG F(AB')2 FRAGMENT FOR ACTIVATION OF THE COMPLEMENT-SYSTEM THROUGH THE ALTERNATIVE PATHWAY .1. DISULFIDE BONDS [J].
ALBAR, JP ;
JUAREZ, C ;
VIVANCOMARTINEZ, F ;
BRAGADO, R ;
ORTIZ, F .
MOLECULAR IMMUNOLOGY, 1981, 18 (10) :925-934
[2]
EHRNST A, 1978, J IMMUNOL, V121, P1206
[3]
ARTHROPATHIC GROUP-A STREPTOCOCCAL CELL-WALLS REQUIRE SPECIFIC ANTIBODY FOR ACTIVATION OF HUMAN-COMPLEMENT BY BOTH THE CLASSICAL AND ALTERNATIVE PATHWAYS [J].
EISENBERG, RA ;
SCHWAB, JH .
INFECTION AND IMMUNITY, 1986, 53 (02) :324-330
[4]
FINE DP, 1972, J IMMUNOL, V109, P807
[5]
ROLE OF COMPLEMENT IN HOST DEFENSE AGAINST EXPERIMENTAL DISSEMINATED CANDIDIASIS [J].
GELFAND, JA ;
HURLEY, DL ;
FAUCI, AS ;
FRANK, MM .
JOURNAL OF INFECTIOUS DISEASES, 1978, 138 (01) :9-16
[6]
Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies [J].
Han, Y ;
Kanbe, T ;
Cherniak, R ;
Cutler, JE .
INFECTION AND IMMUNITY, 1997, 65 (10) :4100-4107
[7]
Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody [J].
Han, Y ;
Riesselman, MH ;
Cutler, JE .
INFECTION AND IMMUNITY, 2000, 68 (03) :1649-1654
[8]
ANTIBODY-RESPONSE THAT PROTECTS AGAINST DISSEMINATED CANDIDIASIS [J].
HAN, YM ;
CUTLER, JE .
INFECTION AND IMMUNITY, 1995, 63 (07) :2714-2719
[9]
Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis [J].
Han, YM ;
Kozel, TR ;
Zhang, MX ;
MacGill, RS ;
Carroll, MC ;
Cutler, JE .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1550-1557
[10]
HECTOR RF, 1982, INFECT IMMUN, V38, P1020, DOI 10.1128/IAI.38.3.1020-1028.1982